ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares

    NEXT STORY
    NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS
    PREV STORY
    DAWOODI BOHRAS OFFER MUCH-NEEDED SUPPORT TO THE ELDERLY
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Mateon Announces Initiation of FOCUS Study in Platinum-Resistant Ovarian Cancer

    SOUTH SAN FRANCISCO, Calif., June 23, 2016 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (Nasdaq:MATN), ...

    author_avatar
    NASDAQ Market News

    Omega Commercial Finance Corporation Building Its Board & Management Team to Position Itself for the Long Term

    MIAMI, FL--(Marketwired - Aug 3, 2016) -  Omega Commercial Finance Corporation (OTCQB: OCFN), a ...

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics Reports First Quarter 2017 Financial Results

    Expands ADAPTIR Portfolio and Announces New Bispecific Candidate; Presents Data at the 2016 PEPTALK ...

    author_avatar
    NASDAQ Market News